Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study

Stock Information for Curative Biotechnology Inc Com

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Curative Biotechnology Inc Com

Curative Biotechnology, Inc. Announces Letter to Shareholders
Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.